RESIDUAL DISEASE

Clinical trials for RESIDUAL DISEASE explained in plain language.

Never miss a new study

Get alerted when new RESIDUAL DISEASE trials appear

Sign up with your email to follow new studies for RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 2 Completed 1

Trial tests stronger drug combo to keep blood cancer at bay

Disease control Completed

This study tested if adding two more drugs (ixazomib and dexamethasone) to a standard maintenance drug (lenalidomide) was better at controlling residual multiple myeloma after a stem cell transplant. It involved 42 patients who still had small amounts of cancer detectable after t…

Matched conditions: RESIDUAL DISEASE

Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

RESIDUAL DISEASE

Get alerted when new RESIDUAL DISEASE trials appear

Trial tests stronger drug combo to keep blood cancer at bay